224 related articles for article (PubMed ID: 32458709)
1. A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape.
Lum C; Prenen H; Body A; Lam M; Segelov E
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):665-680. PubMed ID: 32458709
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.
Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY
Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Anal Cancer.
Dhawan N; Afzal MZ; Amin M
Curr Oncol; 2023 Apr; 30(5):4538-4550. PubMed ID: 37232801
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccines and anal carcinoma.
Franceschi S; De Vuyst H
Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
[TBL] [Abstract][Full Text] [Related]
5. Management of anal intraepithelial neoplasia and anal squamous cell carcinoma at a tertiary referral centre with a dedicated infectious diseases unit: an 18-year review.
Power Foley M; Kelly ME; Kerr C; Kennedy C; Gallagher D; Gillham C; Mehigan BJ; McCormick PH; Bergin C; Larkin JO
Int J Colorectal Dis; 2020 Oct; 35(10):1855-1864. PubMed ID: 32500433
[TBL] [Abstract][Full Text] [Related]
6. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
Poljak M; Šterbenc A; Lunar MM
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
[TBL] [Abstract][Full Text] [Related]
7. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.
Tong WW; Hillman RJ; Kelleher AD; Grulich AE; Carr A
HIV Med; 2014 Feb; 15(2):65-76. PubMed ID: 24007498
[TBL] [Abstract][Full Text] [Related]
8. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
[TBL] [Abstract][Full Text] [Related]
9. Anal cancer: an overview.
Uronis HE; Bendell JC
Oncologist; 2007 May; 12(5):524-34. PubMed ID: 17522240
[TBL] [Abstract][Full Text] [Related]
10. Optimal management of squamous cell carcinoma of the anal canal: where are we now?
Eng C; Ahmed S
Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the management of anal cancer.
Symer MM; Yeo HL
F1000Res; 2018; 7():. PubMed ID: 30345012
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
[TBL] [Abstract][Full Text] [Related]
13. Investigational drugs for treating anal cancer and future perspectives.
Bustamante L; Frakes J; Hoffe S; Kim R
Expert Opin Investig Drugs; 2016; 25(1):51-62. PubMed ID: 26560877
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India.
Gautam A; Chakravarty J; Singh VK; Ghosh A; Chauhan SB; Rai M; Sundar S
BMC Infect Dis; 2018 Dec; 18(1):692. PubMed ID: 30587145
[TBL] [Abstract][Full Text] [Related]
15. HPV-Associated Anal Cancer in the HIV/AIDS Patient.
Wang CJ; Palefsky JM
Cancer Treat Res; 2019; 177():183-209. PubMed ID: 30523625
[TBL] [Abstract][Full Text] [Related]
16. Anal Cancer: Emerging Standards in a Rare Disease.
Eng C; Ciombor KK; Cho M; Dorth JA; Rajdev LN; Horowitz DP; Gollub MJ; Jácome AA; Lockney NA; Muldoon RL; Washington MK; O'Brian BA; Benny A; Lebeck Lee CM; Benson AB; Goodman KA; Morris VK
J Clin Oncol; 2022 Aug; 40(24):2774-2788. PubMed ID: 35649196
[TBL] [Abstract][Full Text] [Related]
17. Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes.
O'brien SJ; Gaskins JT; Ellis CT; Martin BA; Mcdowell J; Gondim DD; Galandiuk S
Cancer Med; 2023 May; 12(10):11462-11474. PubMed ID: 36991580
[TBL] [Abstract][Full Text] [Related]
18. The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.
Mensah FA; Mehta MR; Lewis JS; Lockhart AC
Oncologist; 2016 Apr; 21(4):453-60. PubMed ID: 26961923
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
[TBL] [Abstract][Full Text] [Related]
20. Screening and risk factors for anal cancer precursors in men infected with HIV in Taiwan.
Cheng SH; Chu FY; Wang CC; Hsueh YM
J Med Virol; 2014 Feb; 86(2):193-201. PubMed ID: 24166485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]